COVID-19 research
Gene: CLPB
agree with green geneCreated: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
YES- this is covered on our targeted exomeCreated: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
Gene rating submitted by Kimberly Gilmour and Austen Worth on behalf of London North GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email 6th September the Specialist Test Group all agreed there is enough evidence to rate this gene Green.Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
Gene rating submitted by Tracy Briggs, David Gokhale and Abigal Rousseau on behalf of North West GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email on 20th June the Specialist Test Group all agreed there is enough evidence to rate this gene Green.Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
OriginaI Metadata from IUIS classification table (February, 2018) downloaded 20180614. IUIS Genetic defect (original gene symbol in IUIS download): CLPB .PanelApp HGNC gene symbol check: CLPB . IUIS Disease: 3-Methylglutaconic aciduria . IUIS Inheritance: AR .T cells: N/A, .B cells: N/A, .IUIS Other affected cells: N. IUIS Associated features: Neurocognitive developmental aberrations, microcephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGR. IUIS Major category: Congenital defects of phagocyte number or function. IUIS Subcategory: Congenital NeutropeniasCreated: 2 Jul 2018, 10:35 a.m.
Comment on publications: Capo-Chichi et al. (2015) PMID: 25650066 identified a homozygous truncating mutation in the CLPB gene (616254.0010) that segregated with the disorder in the family. The mutation was found by a combination of homozygosity mapping and exome sequencing and confirmed by Sanger sequencingCreated: 4 Jun 2018, 1:53 p.m.
Comment on list classification: changed from Amber to Green enough evidence to support immune dysfunction -recurrent or severe infection is observed in a large number of unrelated patients described with 3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia (MEGCANN) see PMID: 25597510, 25597511,25650066, 28687938, 26916670 and with over 14 pathogenic variants with a range of molecular consequences.Created: 4 Jun 2018, 1:48 p.m.
Comment on publications: Wortmann et al. (2015) PMID:25597510 described 14 individuals from 9 unrelated families with 3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia, which is also referred to as 3-methylglutaconic aciduria type VII, and identified 14 different homozygous or compound heterozygous mutations in the CLPB gene. Then, Saunders et al. (2015) PMID: 25597511 further described patients, including 2 sibs, of Greenlandic descent identifying a homozygous missense mutation in the CLPB gene.Created: 4 Jun 2018, 1:48 p.m.
Comment on phenotypes: added MIMid from OMIM and phenotype from Orphanet. The phenotype is highly variable: most patients have infantile onset of a progressive encephalopathy with various movement abnormalities and delayed psychomotor development, although rare patients with normal neurologic development have been reported.
The neurological presentation ranges from normal development without intellectual deficits to a severe and progressive encephalopathy associated with muscular hypertonia, progressive brain atrophy and movement disorder. Additionally, cataracts, neutropenia, infections and leukaemia are reported. All patients share an elevated urinary excretion of 3-methylglutaconic acid (3-MGA) as a characteristic biomarker ( Pronicka et al. 2017 PMID: 28687938 )Created: 4 Jun 2018, 1:35 p.m.
This gene was absent from the original PanelApp PID panel dataset (review April 2018). However it was listed in external expert immunodeficiency diagnostic gene list(s) GOSH or GRID. In this combined PID panel, this gene has been rated as AMBER and needs further curational review to assess pertinence prior to v1.Created: 20 Apr 2018, 12:25 p.m.
Original metadata supplied by GRID. GRID Gene Symbol HGNC PanelApp check: CLPB, GRID_Gene_Symbol: CLPB, GRID_Transcript_ENS_Community submitted: ENST00000294053, GRID_Transcript_RefSeq: NM_030813.5, GRID_Transcript_ENS_used_on_Production: ENST00000294053Created: 17 Apr 2018, 12:12 p.m.
gene: CLPB was added gene: CLPB was added to Viral susceptibility. Sources: Expert Review Green,Victorian Clinical Genetics Services,North West GLH,GRID V2.0,NHS GMS,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: CLPB was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CLPB were set to 25650066; 25597510; 27891836; 28687938; 26916670; 25597511 Phenotypes for gene: CLPB were set to Neurocognitive developmental aberrations, microcephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGR; Congenital defects of phagocyte number or function; 3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271; 3-methylglutaconic aciduria, type VII; 3-methylglutaconic aciduria, type 7; Recurrent or severe infection